View in EDS HTML Full Text PDF Full Text

Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.

Saved in:
Bibliographic Details
Title: Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.
Authors: Guerrouahen B; Research Department, Sidra Medicine, Doha, Qatar., Elnaggar M; Research Department, Sidra Medicine, Doha, Qatar., Al-Mohannadi A; Research Department, Sidra Medicine, Doha, Qatar., Kizhakayil D; Research Department, Sidra Medicine, Doha, Qatar., Bonini C; Experimental Hematology Unit, University Vita-Salute San Raffaele and Hospital San Raffaele Scientific Institute, Milan, Italy., Benjamin R; Division of Cancer Studies, King's College Hospital, London, United Kingdom., Brentjens R; Cellular Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Buchholz CJ; Research Unit for Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Casorati G; Experimental Immunology Unit, University Vita-Salute San Raffaele and Hospital San Raffaele Scientific Institute, Milan, Italy., Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States., Martin F; Pfizer/University of Granada/Andalusian Regional Government, Genomic Medicine Department, Granada, Spain., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boson, MA, United States., Turtle C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Veys P; Bone Marrow Transplant Unit, Great Ormond Street (GOS) Hospital, and University College London GOS Institute of Child Health, London, United Kingdom., van der Vliet HJ; Hans van Der Vliet, Department of Medical Oncology, Amsterdam UMC, VU University and Cancer Center, Amsterdam, Netherlands.; Lava Therapeutics, Utrecht, Netherlands., Maccalli C; Research Department, Sidra Medicine, Doha, Qatar.
Corporate Authors: EICCI Faculty Group
Source: Frontiers in immunology [Front Immunol] 2021 Jan 14; Vol. 11, pp. 589381. Date of Electronic Publication: 2021 Jan 14 (Print Publication: 2020).
Publication Type: Conference Proceedings; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33584653
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15<superscript>th</superscript>-16<superscript>th</superscript> February 2019, Doha, Qatar.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guerrouahen+B%22">Guerrouahen B</searchLink>; Research Department, Sidra Medicine, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Elnaggar+M%22">Elnaggar M</searchLink>; Research Department, Sidra Medicine, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Mohannadi+A%22">Al-Mohannadi A</searchLink>; Research Department, Sidra Medicine, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Kizhakayil+D%22">Kizhakayil D</searchLink>; Research Department, Sidra Medicine, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Bonini+C%22">Bonini C</searchLink>; Experimental Hematology Unit, University Vita-Salute San Raffaele and Hospital San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Benjamin+R%22">Benjamin R</searchLink>; Division of Cancer Studies, King's College Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brentjens+R%22">Brentjens R</searchLink>; Cellular Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Buchholz+CJ%22">Buchholz CJ</searchLink>; Research Unit for Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.<br /><searchLink fieldCode="AU" term="%22Casorati+G%22">Casorati G</searchLink>; Experimental Immunology Unit, University Vita-Salute San Raffaele and Hospital San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ferrone+S%22">Ferrone S</searchLink>; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Locke+FL%22">Locke FL</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Martin+F%22">Martin F</searchLink>; Pfizer/University of Granada/Andalusian Regional Government, Genomic Medicine Department, Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Schambach+A%22">Schambach A</searchLink>; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boson, MA, United States.<br /><searchLink fieldCode="AU" term="%22Turtle+C%22">Turtle C</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Veys+P%22">Veys P</searchLink>; Bone Marrow Transplant Unit, Great Ormond Street (GOS) Hospital, and University College London GOS Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22van+der+Vliet+HJ%22">van der Vliet HJ</searchLink>; Hans van Der Vliet, Department of Medical Oncology, Amsterdam UMC, VU University and Cancer Center, Amsterdam, Netherlands.; Lava Therapeutics, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Maccalli+C%22">Maccalli C</searchLink>; Research Department, Sidra Medicine, Doha, Qatar.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22EICCI+Faculty+Group%22">EICCI Faculty Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Jan 14; Vol. 11, pp. 589381. <i>Date of Electronic Publication: </i>2021 Jan 14 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Conference Proceedings; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33584653
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2020.589381
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 589381
    Titles:
      – TitleFull: Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guerrouahen B
      – PersonEntity:
          Name:
            NameFull: Elnaggar M
      – PersonEntity:
          Name:
            NameFull: Al-Mohannadi A
      – PersonEntity:
          Name:
            NameFull: Kizhakayil D
      – PersonEntity:
          Name:
            NameFull: Bonini C
      – PersonEntity:
          Name:
            NameFull: Benjamin R
      – PersonEntity:
          Name:
            NameFull: Brentjens R
      – PersonEntity:
          Name:
            NameFull: Buchholz CJ
      – PersonEntity:
          Name:
            NameFull: Casorati G
      – PersonEntity:
          Name:
            NameFull: Ferrone S
      – PersonEntity:
          Name:
            NameFull: Locke FL
      – PersonEntity:
          Name:
            NameFull: Martin F
      – PersonEntity:
          Name:
            NameFull: Schambach A
      – PersonEntity:
          Name:
            NameFull: Turtle C
      – PersonEntity:
          Name:
            NameFull: Veys P
      – PersonEntity:
          Name:
            NameFull: van der Vliet HJ
      – PersonEntity:
          Name:
            NameFull: Maccalli C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 01
              Text: 2021 Jan 14
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1